BMRN vs NEWTH
Biomarin Pharmaceutical Inc (BMRN) versus NewtekOne, Inc. 8.625% Fixed Rate Senior Notes due 2029 (NEWTH) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
NewtekOne, Inc. 8.625% Fixed Rate Senior Notes due 2029 (NEWTH) common stock listed on US.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
NEWTH does not have a complete income-statement cache yet.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. NEWTH currently screens at market cap $0.
Not investment advice. Open the BMRN and NEWTH stock pages for the full models.
Not investment advice.